Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionReferences
UNFPA Briefing paper. The right to contraceptive information and services for women and adolescents. UNFPA 2010 http://www.unfpa.org/webdav/site/global/shared/documents/publications/2011/Contraception.pdf. Accessed 30.7.2012.
- Use of human rights to meet the unmet need for family planning.Lancet. 2012; 14: 172-180
- Family planning: the essential link to achieving all eight Millennium Development Goals.Contraception. 2010; 81: 460-461
UN. Millennium Development Goals Indicator, Unmet need for family planning. http://mdgs.un.org/unsd/mdg/SeriesDetail.aspx?srid=778. Accessed 30.7.2012.
- Addressing global health, economic, and environmental problems through family planning.Obstet Gynecol. 2011; 117: 1394-1398
Singh S, Darroch JE, Guttmacher Institute and UNFPA, Adding it up: cost and benefits of contraceptive services estimates 2012. http://www.guttmacher.org/pubs/AIU-2012-estimates.pdf. Accessed 30.7.2012.
McCleary-Sills J, McGonagle A, Malhotra A, Women's Demand for Reproductive Control: Understanding and Addressing Gender Barriers, Washington, DC: International Center for Research on Women, 2012 http://www.icrw.org/files/publications/Womens-demand-for-reproductive-control.pdf. Accessed 30.7.2012.
UNICEF State of the world's children 2012. http://www.unicef.org/sowc2012/pdfs/SOWC-2012-TABLE-8-WOMEN.pdf. Accessed 30.7.2012.
World Health Organization, Postnatal care. http://www.who.int/maternal_child_adolescent/topics/newborn/postnatal_care/en/. Accessed 7.8.2012.
- Contraceptive use, intention to use and unmet need uring the postpartum period.Int Fam Plan Perspect. 2001; 27 (Accessed 6.8.2012)
World Health Organization, United Nations Population Fund, UNICEF, The World Bank 2006 Pregnancy, childbirth, postpartum and newborn care, A guide for essential practice. http://whqlibdoc.who.int/publications/2006/924159084X_eng.pdf. Accessed 30.7.2012.
- Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability.Contraception. 2012; 85: 453-457
- Contraceptive effect of extended lactional amenorrhoea: beyond the Bellagio Consensus.Lancet. 1991; 23: 715-717
- Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depoMPA.J Clin Endocrinol Metab. 1977; 44: 32-38
UNICEF State of the world's children 2012. http://www.unicef.org/sowc2012/pdfs/SOWC-2012-TABLE-2-NUTRITION.pdf. Accessed 30.7.2012.
- Dedicated providers of long-acting reversible contraception: new approach in Zambia.Contraception. 2011; 83: 447-452
Contraceptive Commodities for Women's Health. http://www.unfpa.org/webdav/site/global/shared/images/publications/2012/UN%20Commission_%20FP%20Synthesis_%20Final%2019%20March%202012.pdf. Accessed 28.11.2012.
- Sino-implant (II)—a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials.Contraception. 2010; 81: 197-201
Sivin I, Nash H, Waldman S. Jadelle® Levonorgestrel Rod Implants: A Summary of Scientific Data and Lessons Learned from Programmatic Experience. http://www.popcouncil.org/pdfs/jadelle_monograph.pdf. Accessed 19.10.2012.
- Full-term pregnancy with Implanon in situ.J Fam Plann Reprod Health Care. 2006; 32: 268
- Full-term pregnancy with Implanon in situ.J Fam Plann Reprod Health Care. 2006; 32: 268
- Full-term pregnancy with Implanon in situ.J Fam Plann Reprod Health Care. 2006; 32: 268
- Full-term pregnancy with Implanon in situ.J Fam Plann Reprod Health Care. 2006; 32: 204
- Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants.Contraception. 2001; 64: 43-49
- Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy BMC women: an open-label, randomised, crossover trial.Clin Pharmacol. 2012; 12: 8
NIMS USA. http://www.mims.com/USA/drug/info/levonorgestrel/.
Davis D, Review prepared for the FDA in 2001 Teratogenic Risk of Hormonal Products for Contraception: A Review of the Literature, http://www.fda.gov/ohrms/dockets/ac/03/briefing/4015B1_14_FDA-Tab%205-3-Teratogen%20Review.pdf. Accessed 30.7.2012
- Progesterone supplementation and the prevention of preterm birth.Rev Obstet Gynecol. 2011; 4: 60-72
- Environmental induction of the fetal epigenome.Expert Rev Obstet Gynecol. 2010; 5: 657-664
- Contraception and health.Lancet. 2012; 380: 149-156
- Principles of Biomedical Ethics. 6th ed. Oxford University Press, New York, NY2009
- World contraceptive use, 2009 (wall chart). United Nations Population Division, New York2009
